NCT06615986View on ClinicalTrials.gov

Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

April 15, 2027

Study Completion Date

May 15, 2027

Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Cardiosyn

Two sachets by mouth daily. Each dose (sachet) is 8.1 grams. For 2 doses it will be 16.2 grams per person per day.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH